Shionogi Co Ltd - Shionogi's U.S. Unit Receives FDA Approval For Ensitrelvir As Post-Exposure Prophylaxis For Covid-19 - TradingView
TradingView reports on Shionogi Co Ltd - Shionogi's U.S. Unit Receives FDA Approval For Ensitrelvir As Post-Exposure Prophylaxis For Covid-19 in Science & Health.
Take A Coffee NEWS Staff··2 min read
TradingView reported Shionogi Co Ltd - Shionogi's U.S. Unit Receives FDA Approval For Ensitrelvir As Post-Exposure Prophylaxis For Covid-19. Take A Coffee NEWS is tracking the story on the Science & Health desk for readers following medicine, public health, research, climate, space, and science policy.
Source
Why it matters
The story belongs in this desk because it may affect readers tracking medicine, public health, research, climate, space, and science policy.